1. Home
  2. HUGE
  3. HUGE News

Latest FSD Pharma Inc. Class B Subordinate Voting Shares (HUGE) News on July 26, 2024

24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma
HUGE

Newsfile

a day ago

24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
HUGE

Newsfile

3 days ago

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
HUGE

Newsfile

3 days ago

24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma

FSD Pharma Files Amended and Restated Material Change Report
HUGE

Newsfile

22 days ago

FSD Pharma Files Amended and Restated Material Change Report

FSD Pharma provides Corporate Update
HUGE

ACCESSWIRE

a month ago

FSD Pharma provides Corporate Update

HUGE

MT Newswires

a month ago

Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO

HUGE

MT Newswires

a month ago

Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO

HUGE

MT Newswires

a month ago

FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO

FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
HUGE

ACCESSWIRE

a month ago

FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
HUGE

ACCESSWIRE

a month ago

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
HUGE

ACCESSWIRE

a month ago

FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications

FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
HUGE

ACCESSWIRE

2 months ago

FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication

HUGE

Market Exclusive

2 months ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 6/2/24

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
HUGE

ACCESSWIRE

2 months ago

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest

HUGE

MT Newswires

2 months ago

FSD Pharma Slightly Lower In US Premarket As Submits Clinical Trial Protocol to Study Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
HUGE

ACCESSWIRE

2 months ago

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication

FSD Pharma Provides Corporate Update
HUGE

ACCESSWIRE

2 months ago

FSD Pharma Provides Corporate Update

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
HUGE

ACCESSWIRE

2 months ago

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)

FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia

FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication

HUGE

MT Newswires

3 months ago

FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement

FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)

FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)

FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
HUGE

ACCESSWIRE

3 months ago

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption

HUGE

Newsfile

4 months ago

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

FSD Pharma Announces Filing of Year-End 2023 Results
HUGE

ACCESSWIRE

4 months ago

FSD Pharma Announces Filing of Year-End 2023 Results

FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
HUGE

ACCESSWIRE

4 months ago

FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults

FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)
HUGE

ACCESSWIRE

5 months ago

FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM)

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
HUGE

ACCESSWIRE

5 months ago

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum

FSD Pharma Announces Debt Settlement
HUGE

ACCESSWIRE

5 months ago

FSD Pharma Announces Debt Settlement

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
HUGE

ACCESSWIRE

5 months ago

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)

FSD Pharma Announces US ATM Offering
HUGE

ACCESSWIRE

5 months ago

FSD Pharma Announces US ATM Offering

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
HUGE

ACCESSWIRE

6 months ago

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
HUGE

ACCESSWIRE

6 months ago

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates

HUGE

Associated Press Finance

6 months ago

Financial Institutions: Q4 Earnings Snapshot

HUGE

Business Wire

6 months ago

Wag! To Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

Manitex International Appoints Shinichi Iimura to Board of Directors
HUGE

Business Wire

6 months ago

Manitex International Appoints Shinichi Iimura to Board of Directors

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
HUGE

PR Newswire

6 months ago

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
HUGE

PR Newswire

6 months ago

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services
HUGE

Zacks

6 months ago

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services

Wag! Pet Care Solutions Now Available through Bright Horizons
HUGE

Business Wire

6 months ago

Wag! Pet Care Solutions Now Available through Bright Horizons

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
HUGE

ACCESSWIRE

6 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot

HUGE

GlobeNewswire

6 months ago

TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP. ANNOUNCE FORM S-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT

3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
HUGE

InvestorPlace

6 months ago

3 Penny Stocks to Buy to Unlock 2,500% Upside Potential

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
HUGE

GlobeNewswire

6 months ago

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case

Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
HUGE

PR Newswire

7 months ago

Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024

How Couchbase (BASE) Stock Stands Out in a Strong Industry
HUGE

Zacks

7 months ago

How Couchbase (BASE) Stock Stands Out in a Strong Industry

Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
HUGE

Business Wire

7 months ago

Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance

Novo Nordisk enters research partnerships with biotech firms
HUGE

Yahoo Finance Video

7 months ago

Novo Nordisk enters research partnerships with biotech firms

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
HUGE

InvestorPlace

7 months ago

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

Should Value Investors Buy APi Group (APG) Stock?
HUGE

Zacks

7 months ago

Should Value Investors Buy APi Group (APG) Stock?

Pioneer Power Announces e-Bloc and Related Product Orders in Excess of $10 Million
HUGE

Business Wire

7 months ago

Pioneer Power Announces e-Bloc and Related Product Orders in Excess of $10 Million

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
HUGE

ACCESSWIRE

7 months ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC

Pixelworks Enables Lifelike Visual Display on HONOR 90 GT Smartphone
HUGE

PR Newswire

7 months ago

Pixelworks Enables Lifelike Visual Display on HONOR 90 GT Smartphone

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
HUGE

GlobeNewswire

7 months ago

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

Pioneer Power Announces e-Boost Orders Totaling $3.1 Million
HUGE

Business Wire

7 months ago

Pioneer Power Announces e-Boost Orders Totaling $3.1 Million

HUGE

Business Wire

7 months ago

CI&T Receives 2023 AWS Partner Award

Are Medical Stocks Lagging Bausch Health (BHC) This Year?
HUGE

Zacks

7 months ago

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Vital Farms’ New Pause Ad Activation Celebrates Those Who Don’t Get to Pause, Even During Holidays: Farmers
HUGE

GlobeNewswire

7 months ago

Vital Farms’ New Pause Ad Activation Celebrates Those Who Don’t Get to Pause, Even During Holidays: Farmers

HUGE

Business Wire

7 months ago

CI&T at NRF 2024 Showcases Commerce Solutions for the Future of Retail

Vital Farms to Participate in January 2024 Investor Conferences
HUGE

GlobeNewswire

7 months ago

Vital Farms to Participate in January 2024 Investor Conferences

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024
HUGE

GlobeNewswire

7 months ago

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024

HUGE

Business Wire

8 months ago

The Beachbody Company, Inc. Announces $5,300,000 Registered Direct Offering

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders
HUGE

Simply Wall St.

8 months ago

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders

Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency
HUGE

GlobeNewswire

8 months ago

Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
HUGE

PR Newswire

8 months ago

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

FSD Pharma Inc. Announces Closing of Private Placement
HUGE

ACCESSWIRE

8 months ago

FSD Pharma Inc. Announces Closing of Private Placement

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
HUGE

GlobeNewswire

8 months ago

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

Culp Announces Results for Second Quarter Fiscal 2024, With Continued Sequential and Strong Year-Over-Year Operating Improvement and a Solid Financial Position
HUGE

Business Wire

8 months ago

Culp Announces Results for Second Quarter Fiscal 2024, With Continued Sequential and Strong Year-Over-Year Operating Improvement and a Solid Financial Position

Will Weakness in CI&T Inc's (NYSE:CINT) Stock Prove Temporary Given Strong Fundamentals?
HUGE

Simply Wall St.

8 months ago

Will Weakness in CI&T Inc's (NYSE:CINT) Stock Prove Temporary Given Strong Fundamentals?

HUGE

Business Wire

8 months ago

Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)
HUGE

Business Wire

8 months ago

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
HUGE

ACCESSWIRE

8 months ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness
HUGE

ACCESSWIRE

8 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement
HUGE

ACCESSWIRE

8 months ago

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

BODi Helps End After-Dinner Suffering This Thanksgiving
HUGE

Business Wire

8 months ago

BODi Helps End After-Dinner Suffering This Thanksgiving

HUGE

Business Wire

8 months ago

The Beachbody Company, Inc. Completes Reverse Stock Split

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?
HUGE

Simply Wall St.

8 months ago

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?

EZCORP, Inc. (NASDAQ:EZPW) Q4 2023 Earnings Call Transcript
HUGE

Insider Monkey

8 months ago

EZCORP, Inc. (NASDAQ:EZPW) Q4 2023 Earnings Call Transcript

HUGE

Thomson Reuters StreetEvents

8 months ago

Q4 2023 EZCORP Inc Earnings Call

Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules
HUGE

Business Wire

8 months ago

Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules

HUGE

PR Newswire

8 months ago

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.

EZCORP Inc (EZPW) Reports Record Revenue Over $1 Billion in FY2023
HUGE

GuruFocus.com

8 months ago

EZCORP Inc (EZPW) Reports Record Revenue Over $1 Billion in FY2023

Bakkt Reports Third Quarter 2023 Results
HUGE

Business Wire

8 months ago

Bakkt Reports Third Quarter 2023 Results

HUGE

Associated Press Finance

8 months ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
HUGE

PR Newswire

8 months ago

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Here’s What Makes Sono-Tek (SOTK) a Wise Investment Choice
HUGE

Insider Monkey

8 months ago

Here’s What Makes Sono-Tek (SOTK) a Wise Investment Choice

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story
HUGE

Simply Wall St.

8 months ago

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Warby Parker Inc. (NYSE:WRBY) Q3 2023 Earnings Call Transcript
HUGE

Insider Monkey

9 months ago

Warby Parker Inc. (NYSE:WRBY) Q3 2023 Earnings Call Transcript

With A 29% Price Drop For Warby Parker Inc. (NYSE:WRBY) You'll Still Get What You Pay For
HUGE

Simply Wall St.

9 months ago

With A 29% Price Drop For Warby Parker Inc. (NYSE:WRBY) You'll Still Get What You Pay For

Bright Health Group, Inc. (NYSE:BHG) Q3 2023 Earnings Call Transcript
HUGE

Insider Monkey

9 months ago

Bright Health Group, Inc. (NYSE:BHG) Q3 2023 Earnings Call Transcript

HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
HUGE

GlobeNewswire

9 months ago

HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting
HUGE

GlobeNewswire

9 months ago

Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting

HUGE

Associated Press Finance

9 months ago

Bright Health: Q3 Earnings Snapshot

Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights
HUGE

GuruFocus.com

9 months ago

Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights

HUGE

GuruFocus.com

9 months ago

Bright Health Group Inc (BHG) Reports Q3 2023 Earnings: Revenue Up 39% YoY, Net Loss of $479. ...

Upland Software (UPLD) Reports Q3 Earnings: What Key Metrics Have to Say
HUGE

Zacks

9 months ago

Upland Software (UPLD) Reports Q3 Earnings: What Key Metrics Have to Say

Established Managed Investment Solutions Team Joins Westwood Holdings Group
HUGE

GlobeNewswire

9 months ago

Established Managed Investment Solutions Team Joins Westwood Holdings Group

Share on Social Networks: